Stocks - New Portfolio

Alex Marin

Stocks
Individual Investor
Ranked #22,399 out of 760,352 TipRanks' Investors
Success Rate
81%
428 out of 531
profitable transactions
Average Return
15.47%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 102.50%
6-Month Return▲ 39.77%
12-Month Return▲ 55.93%
YTD Return▲ 44.22%
Total Return▼ 31.91%

Best Trade

Opened at
Closed at
Gain▲ 244.61%

Bio

Investments

Performance

103.41%0-103.41%
▲ 5.05%
▲ 3.27%
▼ 1.77%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 11.50%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 11.70%
May 2024
▼ 2.25%
▲ 3.53%
▼ 18.56%
Jun 2024
▲ 25.72%
▲ 1.21%
▲ 5.42%
Jul 2024
▼ 4.21%
▲ 2.34%
▼ 11.60%
Aug 2024
▲ 7.81%
▲ 2.10%
▲ 103.41%
Sep 2024
▲ 2.21%
▲ 0.59%
▼ 7.01%
Oct 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 5.05%▲ 3.27%▼ 1.77%
▼ 12.40%▼ 4.03%▼ 11.50%
▲ 11.46%▲ 5.06%▲ 11.70%
▼ 2.25%▲ 3.53%▼ 18.56%
▲ 25.72%▲ 1.21%▲ 5.42%
▼ 4.21%▲ 2.34%▼ 11.60%
▲ 7.81%▲ 2.10%▲ 103.41%
▲ 2.21%▲ 0.59%▼ 7.01%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Liminal BioSciences
▼ 81.48%
2
Close
Sep 25, 2023
Clovis Oncology
▼ 99.78%
4
Close
Jul 11, 2023
GeNeuro SA
▲ 37.88%
2
Close
Feb 17, 2023
Tyme Technologies
▼ 81.98%
2
Close
Sep 16, 2022
Syros Pharmaceuticals
0%
▼ 73.33%
1
Open
Sep 16, 2022
Achieve Life Sciences
0%
▼ 43.92%
1
Open
Jan 11, 2021
Nabriva Therapeutics
0%
▼ 99.82%
1
Open
Jan 11, 2021
Synlogic
0%
▼ 95.96%
1
Open
Jan 11, 2021
Purple Biotech
0%
▲ 3.22%
1
Open
Jan 11, 2021
Pulmatrix
0%
▼ 91.57%
1
Open
Jan 11, 2021
ObsEva
0%
▼ 99.50%
1
Open
Jan 11, 2021
ENDRA Life Sciences
0%
▼ 99.98%
1
Open
Jan 11, 2021
Checkpoint Therapeutics
0%
▼ 91.37%
1
Open
Jan 11, 2021
Galectin Therapeutics
0%
▲ 19.00%
1
Open
Jan 11, 2021
Atossa Therapeutics
0%
▲ 27.27%
1
Open
Jan 11, 2021
Daré Bioscience
0%
▼ 85.58%
1
Open
Jan 11, 2021
Baudax Bio
0%
▼ 100.00%
1
Open
Jan 11, 2021
Galmed Pharmaceuticals
0.03%
▼ 92.57%
1
Open
Dec 09, 2020
Callon
▲ 62.72%
5
Close
Dec 09, 2020
Cenovus Energy
▲ 26.71%
5
Close
Dec 09, 2020